Attached files
file | filename |
---|---|
10-K - FORM 10-K - SPECTRUM PHARMACEUTICALS INC | a58896e10vk.htm |
EX-21 - EX-21 - SPECTRUM PHARMACEUTICALS INC | a58896exv21.htm |
EX-3.1 - EX-3.1 - SPECTRUM PHARMACEUTICALS INC | a58896exv3w1.htm |
EX-23.2 - EX-23.2 - SPECTRUM PHARMACEUTICALS INC | a58896exv23w2.htm |
EX-10.1 - EX-10.1 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w1.htm |
EX-10.6 - EX-10.6 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w6.htm |
EX-23.1 - EX-23.1 - SPECTRUM PHARMACEUTICALS INC | a58896exv23w1.htm |
EX-10.35 - EX-10.35 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w35.htm |
EX-10.18 - EX-10.18 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w18.htm |
EX-10.34 - EX-10.34 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w34.htm |
EX-10.19 - EX-10.19 - SPECTRUM PHARMACEUTICALS INC | a58896exv10w19.htm |
EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INC | a58896exv31w2.htm |
EX-32.2 - EX-32.2 - SPECTRUM PHARMACEUTICALS INC | a58896exv32w2.htm |
EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INC | a58896exv31w1.htm |
EXHIBIT 32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, the undersigned officer of Spectrum Pharmaceuticals, Inc.
(the Company), hereby certifies,
to such officers knowledge, that:
(i) the accompanying Annual Report on
Form 10-K
of the Company for the year ended December 31, 2010 (the
Report) fully complies with the requirements of
Section 13(a) or Section 15(d), as applicable, of the
Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly
presents, in all material respects, the financial condition and
results of operations of the Company.
Dated: March 9, 2011
/s/ RAJESH
C. SHROTRIYA
Rajesh C. Shrotriya, M.D.
Chairman, Chief Executive Officer and President
This certification accompanies this Report pursuant to
Rule 13a-14(b)
or
Rule 15d-14(b)
under the Securities Exchange Act of 1934, as amended, and
18 U.S.C. Section 1350 and shall not be deemed filed
by the Company for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended.